moa glp 1 agonist Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1 Evolution of GLP‐1 Receptor Agonists

Rappaport and K

Supports restful, refreshing sleep as part of your nighttime routine

(A) TIDE analysis of GSS , SRM and HMBS CRISPR/Cas9 knockouts in TaC12 and BoMac cells

Results: nejm.org/doi/full/10.10 #ADA2023 Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released phase 2 trial results demonstrating 25% weight loss in half of people with #obesity

The number of human peripheral blood CD4 + CD25 high regulatory T cells increases with age

For wellness-focused clients without confirmed deficiency, many practitioners offer monthly injections, though this should be supported by appropriate assessment and documentation